USPTO serial 79184029
DEEPLEX
Reviewed by CopyMark Law Group
Reg. 5319161Status 707Renewal
- Filing date
- Status date
- Registration date
- Oct 31, 2017
- Examiner
- SPARACINO, MARK V
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DEEPLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHAI IM
CHAI IM H&I PARTNERS LLC2146 ORCHARD MIST STREETLAS VEGAS, NY 89135UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Scientific apparatus and instruments for use in science, research and industry, namely, scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomic, genetics, and life sciences; ] scientific apparatus kits comprised of scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid flora, metagenomes, microorganisms, microbiota or transcriptomics, and reagents for DNA extraction, DNA amplification, sequencing libraries preparation and sequencing in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; [ analytical instruments, namely, scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomic, genetics, and life sciences; ] [ data processors; computer programs and software for research, testing and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics, agri-food and in the processing of biological data; ] computer programs for scientific analysis of genetic sequences and biological platelets for use in scientific research; computer programs for identifying DNA, detecting diseases, analyzing data in the agri-food field, and testing and developing drugs [ ; diagnostic apparatus, not for medical use, namely, sequencers, analyzers and computer hardware, diagnostics apparatus for testing food, water, air, soils, blood and other bodily fluids, diagnostics apparatus for DNA analysis; measuring instruments, namely, electronic quantity indicators for measuring blood and other bodily fluids; DNA chips ] | ACTIVE | — |
| 010 | [ Medical and veterinary apparatus and instruments, namely, sequencers and analyzers for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; medical diagnostic apparatus for use in testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases, medical diagnostic apparatus for use in testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases ] | SECTION 71 - CANCELLED | — |
| 038 | [ Provision of access to databases; providing access to on-line computer databases; rental of access time to global computer networks; ] [ providing access to computer databases containing information based on human genome sequencer results; providing internet access to electronic libraries of biological markers; providing multiple user access to proprietary collections of information about biological markers by means of global computer information networks ] [ ; provision of access to a global computer network; providing user access to computer programs in data networks; provision of access to data or documents stored electronically in central files for remote consultation ] | SECTION 7(e) - CANCELLED | — |
| 042 | [ Evaluations, analyses, scientific research and technological testing services of flora, metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; biomedical research, and biological, medical and veterinary product development, gene expression analysis and protein profiling for scientific research purposes; providing laboratory research services in the field of gene expression and protein profiling, namely, cancer, infectious diseases, tuberculosis, Alzheimer biology; ] genotyping services for scientific research and analysis purposes and genotyping based on biological markers for scientific research and analysis purposes; design and development of programming databases in the fields of pharmaceuticals, biology, agri-food, biotechnology, biochemistry, genomics, transcriptomics, genetics and life sciences; clinical laboratory testing services, namely, gene sequencing-based testing services with a view to research relating to genome sequencing of plants and animals, micro-organisms, sequencing of DNA or RNA and epigenetic sequencing; development and updating of computer programs designed for scientific analysis of genetic sequences, genetic sequencing of the genes of individuals and cohorts; electronic data storage and computer programming services for publishing data in a computer science environment designed for bioinformatics; bioinformatics computer engineering services; laboratory research services in the field of large-scale DNA sequencing; development and updating of data management systems; database design and development and design and development of computer applications for general and biological data processing; scientific research, development and validation of micro-satellite and mini-satellite genetic markers; scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes including human animal, micro-organisms, namely, identification, typing, tracing, analysis, creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, mutation detection and identification of microorganisms and mini-satellite markers; scientific research, namely, mutation detection and identification of microorganisms; genotyping services for research or analyses purposes; development and testing of computer databases, software, algorithms and computing methods for generating and analyzing biological, genetic and epidemiological data; scientific research and development services in the fields of diagnostic methods, antibody technology, and gene expression systems; [ scientific research and development services; medical laboratory services; ] scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes including human animal, micro-organisms, namely, identification, typing, tracing, analysis, creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, scientific research services, namely, mutation detection and identification of microorganisms and mini-satellite markers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENOSCREEN
- Other trademarks owned by GENOSCREEN
- Other trademarks owned by GENOSCREEN
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named DEEPLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 20, 2026 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Apr 18, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 18, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 6, 2026 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 9, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 27, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 26, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 29, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 11, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 11, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 10, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 9, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 4, 2025 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 4, 2025 | INPC | INVALIDATION PROCESSED | — |
| Apr 14, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 6, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 6, 2024 | NA15 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | — |
| Aug 6, 2024 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| Aug 6, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 6, 2024 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jul 15, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 30, 2023 | E15R | TEAS SECTION 15 RECEIVED | — |
| Oct 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 31, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 27, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 30, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 1, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 1, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 31, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 15, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 11, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 9, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 9, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 26, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 26, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 26, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 12, 2017 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| May 12, 2017 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| May 12, 2017 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| May 4, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 3, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 3, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 3, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 3, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 3, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 18, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 14, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2016 | ALIE | ASSIGNED TO LIE | — |
| Sep 23, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 23, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 22, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |